<DOC>
	<DOCNO>NCT01055405</DOCNO>
	<brief_summary>Sildenafil phosphodiesterase-5 inhibitor approve treatment pulmonary arterial hypertension orphan drug designation . Sildenafil modulate nitric oxide ( NO ) pathway vessel wall . Since pathway impaired pulmonary artery patient pulmonary hypertension ( PH ) associate chronic obstructive pulmonary disease ( COPD ) , investigator hypothesize sildenafil might improve pulmonary hemodynamics increase exercise tolerance condition .</brief_summary>
	<brief_title>Study Sildenafil Effects Combination With Rehabilitation Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Associated Pulmonary Hypertension</brief_title>
	<detailed_description>It prospective , randomize , double-blind , placebo control trial ass effect 3 month treatment sildenafil ( 20 mg/8 h ) , add pulmonary rehabilitation program , exercise tolerance . Subjects : 60 patient ( 30 treatment group ) . Main end-point variable : endurance time constant work exercise test ( CWET ) . Other measurement : 6 min walk distance , performance incremental exercise test , physiological metabolic response iso-time iso-load CWET , dyspnea , health-related quality life .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>COPD , FEV1 &lt; 80 % ref . FEV1/FVC &lt; 0.7 post bronchodilator Age 4080 year Pulmonary hypertension Consent participate study Pulmonary extrapulmonary disease modifies gas exchange pulmonary hemodynamics Recent exacerbation ( &lt; 4 week ) ( temporally ) Patients treated nitrate CYP3A4 inhibitor ( ketoconazole , itraconazole , ritonavir ) Ischemic optic neuropathy Patients treat phosphodiesterase5 inhibitor Patients ischemic cardiopathy Systemic disease could modify result Patients unable practise exercise</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Exercise tolerance</keyword>
	<keyword>COPD</keyword>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>Sildenafil</keyword>
</DOC>